CCXI Annual EBIT
-$129.06 M
-$76.35 M-144.84%
31 December 2021
Summary:
As of February 5, 2025, CCXI annual earnings before interest & taxes is -$129.06 million, with the most recent change of -$76.35 million (-144.84%) on December 31, 2021. During the last 3 years, it has fallen by -$92.32 million (-251.26%).CCXI EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCXI Quarterly EBIT
-$31.07 M
+$6.95 M+18.27%
30 June 2022
Summary:
As of February 5, 2025, CCXI quarterly earnings before interest & taxes is -$31.07 million, with the most recent change of +$6.95 million (+18.27%) on June 30, 2022. Over the past year, it has increased by +$7.45 million (+19.34%).CCXI Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCXI TTM EBIT
-$130.60 M
+$7.45 M+5.40%
30 June 2022
Summary:
As of February 5, 2025, CCXI TTM earnings before interest & taxes is -$130.60 million, with the most recent change of +$7.45 million (+5.40%) on June 30, 2022. Over the past year, it has dropped by -$10.53 million (-8.77%).CCXI TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CCXI EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -144.8% | +19.3% | -8.8% |
| 3 y3 years | -251.3% | -112.7% | -144.8% |
| 5 y5 years | -822.5% | -236.2% | -144.8% |
CCXI EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -806.0% | -178.3% | -831.1% |
ChemoCentryx EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | -$31.07 M(-18.3%) | -$130.60 M(-5.4%) |
| Mar 2022 | - | -$38.01 M(-4.7%) | -$138.05 M(+7.0%) |
| Dec 2021 | -$129.06 M(+144.8%) | -$39.88 M(+84.3%) | -$129.06 M(+9.0%) |
| Sept 2021 | - | -$21.64 M(-43.8%) | -$118.35 M(-1.4%) |
| June 2021 | - | -$38.51 M(+32.7%) | -$120.07 M(+98.2%) |
| Mar 2021 | - | -$29.02 M(-0.5%) | -$60.60 M(+15.0%) |
| Dec 2020 | -$52.71 M(-1.2%) | -$29.18 M(+24.9%) | -$52.71 M(+36.7%) |
| Sept 2020 | - | -$23.36 M(-211.4%) | -$38.55 M(+40.1%) |
| June 2020 | - | $20.96 M(-199.2%) | -$27.51 M(-56.4%) |
| Mar 2020 | - | -$21.14 M(+40.8%) | -$63.07 M(+18.2%) |
| Dec 2019 | -$53.34 M(+45.2%) | -$15.01 M(+21.8%) | -$53.34 M(+9.6%) |
| Sept 2019 | - | -$12.32 M(-15.6%) | -$48.67 M(+4.0%) |
| June 2019 | - | -$14.60 M(+28.0%) | -$46.82 M(+20.3%) |
| Mar 2019 | - | -$11.41 M(+10.3%) | -$38.91 M(+5.9%) |
| Dec 2018 | -$36.74 M(-305.7%) | -$10.34 M(-1.2%) | -$36.74 M(-377.2%) |
| Sept 2018 | - | -$10.47 M(+56.4%) | $13.26 M(-22.8%) |
| June 2018 | - | -$6.69 M(-27.6%) | $17.16 M(+17.4%) |
| Mar 2018 | - | -$9.24 M(-123.3%) | $14.62 M(-18.2%) |
| Dec 2017 | $17.86 M(-144.7%) | $39.66 M(-704.6%) | $17.86 M(-161.7%) |
| Sept 2017 | - | -$6.56 M(-29.0%) | -$28.95 M(-2.6%) |
| June 2017 | - | -$9.24 M(+54.1%) | -$29.73 M(-3.0%) |
| Mar 2017 | - | -$6.00 M(-16.2%) | -$30.63 M(-23.4%) |
| Dec 2016 | -$39.96 M | -$7.16 M(-2.3%) | -$39.96 M(-9.3%) |
| Sept 2016 | - | -$7.33 M(-27.7%) | -$44.08 M(-9.1%) |
| June 2016 | - | -$10.14 M(-33.8%) | -$48.49 M(-4.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2016 | - | -$15.33 M(+35.9%) | -$50.52 M(+6.8%) |
| Dec 2015 | -$47.30 M(+0.9%) | -$11.28 M(-4.0%) | -$47.30 M(-1.9%) |
| Sept 2015 | - | -$11.74 M(-3.6%) | -$48.22 M(+1.7%) |
| June 2015 | - | -$12.18 M(+0.6%) | -$47.41 M(-0.2%) |
| Mar 2015 | - | -$12.11 M(-0.6%) | -$47.49 M(+1.2%) |
| Dec 2014 | -$46.91 M(+21.5%) | -$12.19 M(+11.4%) | -$46.91 M(+6.0%) |
| Sept 2014 | - | -$10.94 M(-10.8%) | -$44.25 M(+3.6%) |
| June 2014 | - | -$12.26 M(+6.3%) | -$42.73 M(+6.9%) |
| Mar 2014 | - | -$11.53 M(+20.9%) | -$39.96 M(+3.5%) |
| Dec 2013 | -$38.61 M(-1.2%) | -$9.53 M(+1.2%) | -$38.61 M(-0.6%) |
| Sept 2013 | - | -$9.42 M(-0.7%) | -$38.86 M(-1.7%) |
| June 2013 | - | -$9.49 M(-6.8%) | -$39.54 M(-3.4%) |
| Mar 2013 | - | -$10.18 M(+4.1%) | -$40.92 M(+4.7%) |
| Dec 2012 | -$39.10 M(+906.9%) | -$9.78 M(-3.1%) | -$39.10 M(+271.6%) |
| Sept 2012 | - | -$10.10 M(-7.1%) | -$10.52 M(+17.3%) |
| June 2012 | - | -$10.87 M(+30.2%) | -$8.97 M(+50.2%) |
| Mar 2012 | - | -$8.35 M(-144.4%) | -$5.97 M(+53.8%) |
| Dec 2011 | -$3.88 M(+25.7%) | $18.80 M(-320.1%) | -$3.88 M(-77.9%) |
| Sept 2011 | - | -$8.54 M(+8.4%) | -$17.58 M(+2.8%) |
| June 2011 | - | -$7.88 M(+25.8%) | -$17.10 M(+85.4%) |
| Mar 2011 | - | -$6.26 M(-222.7%) | -$9.22 M(+211.4%) |
| Dec 2010 | -$3.09 M(-119.3%) | $5.10 M(-163.3%) | -$2.96 M(-63.3%) |
| Sept 2010 | - | -$8.06 M | -$8.06 M |
| Dec 2009 | $15.99 M(-187.1%) | - | - |
| Dec 2008 | -$18.36 M | - | - |
FAQ
- What is ChemoCentryx annual earnings before interest & taxes?
- What is the all time high annual EBIT for ChemoCentryx?
- What is ChemoCentryx annual EBIT year-on-year change?
- What is ChemoCentryx quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for ChemoCentryx?
- What is ChemoCentryx quarterly EBIT year-on-year change?
- What is ChemoCentryx TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for ChemoCentryx?
- What is ChemoCentryx TTM EBIT year-on-year change?
What is ChemoCentryx annual earnings before interest & taxes?
The current annual EBIT of CCXI is -$129.06 M
What is the all time high annual EBIT for ChemoCentryx?
ChemoCentryx all-time high annual earnings before interest & taxes is $18.28 M
What is ChemoCentryx annual EBIT year-on-year change?
Over the past year, CCXI annual earnings before interest & taxes has changed by -$76.35 M (-144.84%)
What is ChemoCentryx quarterly earnings before interest & taxes?
The current quarterly EBIT of CCXI is -$31.07 M
What is the all time high quarterly EBIT for ChemoCentryx?
ChemoCentryx all-time high quarterly earnings before interest & taxes is $39.66 M
What is ChemoCentryx quarterly EBIT year-on-year change?
Over the past year, CCXI quarterly earnings before interest & taxes has changed by +$7.45 M (+19.34%)
What is ChemoCentryx TTM earnings before interest & taxes?
The current TTM EBIT of CCXI is -$130.60 M
What is the all time high TTM EBIT for ChemoCentryx?
ChemoCentryx all-time high TTM earnings before interest & taxes is $17.86 M
What is ChemoCentryx TTM EBIT year-on-year change?
Over the past year, CCXI TTM earnings before interest & taxes has changed by -$10.53 M (-8.77%)